CL2014001172A1 - Un portador para la liberacion controlada de agentes activos que comprende un nucleo de cabonato de calcio y un agente activo, y un recubrimiento que encapsula al nucleo; metodo para preparar el portador, y su uso en controlar la liberacion de un agente activo - Google Patents
Un portador para la liberacion controlada de agentes activos que comprende un nucleo de cabonato de calcio y un agente activo, y un recubrimiento que encapsula al nucleo; metodo para preparar el portador, y su uso en controlar la liberacion de un agente activoInfo
- Publication number
- CL2014001172A1 CL2014001172A1 CL2014001172A CL2014001172A CL2014001172A1 CL 2014001172 A1 CL2014001172 A1 CL 2014001172A1 CL 2014001172 A CL2014001172 A CL 2014001172A CL 2014001172 A CL2014001172 A CL 2014001172A CL 2014001172 A1 CL2014001172 A1 CL 2014001172A1
- Authority
- CL
- Chile
- Prior art keywords
- carrier
- active agent
- release
- encapsulates
- nucleus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
- A01N25/28—Microcapsules or nanocapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Toxicology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11188597.6A EP2591772B1 (en) | 2011-11-10 | 2011-11-10 | New coated controlled release active agent carriers |
| US201161559253P | 2011-11-14 | 2011-11-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2014001172A1 true CL2014001172A1 (es) | 2014-09-12 |
Family
ID=47143128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2014001172A CL2014001172A1 (es) | 2011-11-10 | 2014-05-06 | Un portador para la liberacion controlada de agentes activos que comprende un nucleo de cabonato de calcio y un agente activo, y un recubrimiento que encapsula al nucleo; metodo para preparar el portador, y su uso en controlar la liberacion de un agente activo |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US9579291B2 (es) |
| EP (1) | EP2747752B1 (es) |
| KR (1) | KR101612655B1 (es) |
| CN (1) | CN103957893B (es) |
| AU (1) | AU2012334082B2 (es) |
| BR (1) | BR112014011310B1 (es) |
| CA (1) | CA2851069C (es) |
| CL (1) | CL2014001172A1 (es) |
| CO (1) | CO6940430A2 (es) |
| DK (1) | DK2747752T3 (es) |
| ES (1) | ES2553091T3 (es) |
| IL (1) | IL231959A0 (es) |
| IN (1) | IN2014MN00843A (es) |
| MX (1) | MX346884B (es) |
| MY (1) | MY168425A (es) |
| PL (1) | PL2747752T3 (es) |
| PT (1) | PT2747752E (es) |
| RU (2) | RU2665382C1 (es) |
| SG (1) | SG11201401350WA (es) |
| SI (1) | SI2747752T1 (es) |
| SM (1) | SMT201600010B (es) |
| TW (1) | TWI625129B (es) |
| WO (1) | WO2013068478A1 (es) |
| ZA (1) | ZA201403611B (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2719376B1 (en) | 2012-10-12 | 2015-03-04 | Omya International AG | Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate |
| AU2014216370A1 (en) * | 2013-02-15 | 2015-08-20 | Wellmark International | Mineral feed-through formulation |
| EP3103844B1 (en) | 2015-06-10 | 2018-08-08 | Omya International AG | Use of surface-reacted calcium carbonate as anti-blocking agent |
| EP3176222A1 (en) * | 2015-12-01 | 2017-06-07 | Omya International AG | Method for the production of granules comprising surface-reacted calcium carbonate |
| CN109071750B (zh) | 2016-03-08 | 2022-08-02 | 生活实验公司 | 持久化妆品组合物 |
| EP3275947A1 (en) * | 2016-07-25 | 2018-01-31 | Omya International AG | Surface-reacted calcium carbonate with functional cations |
| EP3400810A1 (en) * | 2017-05-11 | 2018-11-14 | Omya International AG | Surface-reacted calcium carbonate in food |
| CN107258776A (zh) * | 2017-06-29 | 2017-10-20 | 山东大农药业有限公司 | 一种缓释农药颗粒剂及其制备方法 |
| WO2019055445A2 (en) | 2017-09-13 | 2019-03-21 | Living Proof, Inc. | COLOR PROTECTION COMPOSITIONS |
| CN111133023B (zh) | 2017-09-13 | 2022-10-18 | 生活实验公司 | 持久化妆品组合物 |
| US11510877B2 (en) | 2017-10-10 | 2022-11-29 | Capsugel Belgium Nv | Gelling multiparticulates |
| EP3520798A1 (en) * | 2018-01-31 | 2019-08-07 | Omya International AG | Use of functionalized calcium carbonate as active ingredient |
| WO2020091456A1 (ko) * | 2018-10-31 | 2020-05-07 | ㈜아모레퍼시픽 | 바이오 폴리머를 포함하는 코어-쉘 네트워크 구조체 및 이를 포함하는 조성물 |
| KR20200049662A (ko) * | 2018-10-31 | 2020-05-08 | (주)아모레퍼시픽 | 바이오 폴리머를 포함하는 코어-쉘 네트워크 구조체 및 이를 포함하는 조성물 |
| US20220105047A1 (en) * | 2019-01-16 | 2022-04-07 | Research Cooperation Foundation Of Yeungnam University | Microcapsule composition using alginate gel, and method for producing same |
| KR20210069344A (ko) | 2019-12-03 | 2021-06-11 | (주)아모레퍼시픽 | 바이오 폴리머를 포함하는 효능물질 전달체 |
| CN111436426B (zh) * | 2020-05-11 | 2022-04-08 | 北京首创股份有限公司 | 供水管道输水用二次加氯胶囊及其制备方法 |
| AR123009A1 (es) | 2020-07-20 | 2022-10-19 | Omya Int Ag | Agente estabilizante para composición probiótica |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2223896A1 (de) | 1972-05-17 | 1973-11-29 | Sanol Arznei Schwarz Gmbh | Verfahren zum ueberziehen von feinteiligen arzneimitteln |
| US4657784A (en) | 1986-03-10 | 1987-04-14 | Ecolab Inc. | Process for encapsulating particles with at least two coating layers having different melting points |
| ATE180668T1 (de) * | 1992-12-01 | 1999-06-15 | Spirig Ag | S(+)-ibuprofen enthaltende arzneimittel |
| US5958458A (en) * | 1994-06-15 | 1999-09-28 | Dumex-Alpharma A/S | Pharmaceutical multiple unit particulate formulation in the form of coated cores |
| FR2787802B1 (fr) | 1998-12-24 | 2001-02-02 | Pluss Stauffer Ag | Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications |
| FR2852600B1 (fr) | 2003-03-18 | 2005-06-10 | Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages | |
| FR2871474B1 (fr) | 2004-06-11 | 2006-09-15 | Omya Development Ag | Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages |
| EP1891937A1 (en) | 2006-08-25 | 2008-02-27 | Novartis AG | Galenic formulations of aliskiren |
| ATE459416T1 (de) * | 2007-03-21 | 2010-03-15 | Omya Development Ag | Verfahren zur beseitigung von endokrin wirksamen verbindungen |
| PL2070991T3 (pl) | 2007-12-12 | 2011-02-28 | Omya Int Ag | Sposób wytwarzania strącanego węglanu wapnia o powierzchni zmodyfikowanej chemicznie |
| EP2168572A1 (en) | 2008-09-30 | 2010-03-31 | Omya Development Ag | New controlled release active agent carrier |
| WO2010121620A1 (en) | 2009-04-24 | 2010-10-28 | Fertin Pharma A/S | Particulate material for controlled release of active ingredients |
| ATE542862T1 (de) | 2009-06-15 | 2012-02-15 | Omya Development Ag | Verfahren zur herstellung von oberflächenreaktivem kalziumkarbonat und verwendung |
| PT2264108E (pt) | 2009-06-15 | 2012-05-23 | Omya Development Ag | Processo para preparar um carbonato de cálcio feito reagir em superfície utilizando um ácido fraco |
-
2012
- 2012-10-29 TW TW101139890A patent/TWI625129B/zh not_active IP Right Cessation
- 2012-11-08 PT PT127813467T patent/PT2747752E/pt unknown
- 2012-11-08 SG SG11201401350WA patent/SG11201401350WA/en unknown
- 2012-11-08 US US14/349,850 patent/US9579291B2/en active Active
- 2012-11-08 EP EP12781346.7A patent/EP2747752B1/en active Active
- 2012-11-08 MX MX2014005466A patent/MX346884B/es active IP Right Grant
- 2012-11-08 CN CN201280055056.6A patent/CN103957893B/zh active Active
- 2012-11-08 KR KR1020147015774A patent/KR101612655B1/ko active IP Right Grant
- 2012-11-08 RU RU2014123532A patent/RU2665382C1/ru active
- 2012-11-08 RU RU2018123688A patent/RU2018123688A/ru unknown
- 2012-11-08 BR BR112014011310-6A patent/BR112014011310B1/pt active IP Right Grant
- 2012-11-08 SI SI201230345T patent/SI2747752T1/sl unknown
- 2012-11-08 MY MYPI2014701204A patent/MY168425A/en unknown
- 2012-11-08 ES ES12781346.7T patent/ES2553091T3/es active Active
- 2012-11-08 IN IN843MUN2014 patent/IN2014MN00843A/en unknown
- 2012-11-08 CA CA2851069A patent/CA2851069C/en active Active
- 2012-11-08 PL PL12781346T patent/PL2747752T3/pl unknown
- 2012-11-08 WO PCT/EP2012/072161 patent/WO2013068478A1/en active Application Filing
- 2012-11-08 AU AU2012334082A patent/AU2012334082B2/en active Active
- 2012-11-08 DK DK12781346.7T patent/DK2747752T3/en active
-
2014
- 2014-04-06 IL IL231959A patent/IL231959A0/en unknown
- 2014-04-30 CO CO14093176A patent/CO6940430A2/es unknown
- 2014-05-06 CL CL2014001172A patent/CL2014001172A1/es unknown
- 2014-05-19 ZA ZA2014/03611A patent/ZA201403611B/en unknown
-
2016
- 2016-01-11 SM SM201600010T patent/SMT201600010B/it unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2014001172A1 (es) | Un portador para la liberacion controlada de agentes activos que comprende un nucleo de cabonato de calcio y un agente activo, y un recubrimiento que encapsula al nucleo; metodo para preparar el portador, y su uso en controlar la liberacion de un agente activo | |
| HUS2100024I1 (hu) | Izoxazolint tartalmazó parazita-ellenes készítmények, ezek elõállítása és alkalmazása | |
| CL2014002283A1 (es) | Forma de dosificacion oral solida de liberacion inmediata que comprende particulas que comprenden un nucleo con un primer agente activo, un recubrimiento con un segundo agente activo sobre el y un material sensible al ph acido sobre dicho nucleo recubierto; proceso para prepararla; metodo de tratamiento; y uso para tratar dolor. | |
| HK1202849A1 (en) | Structures and methods for controlling fragrance release using encapsulated fragrance on container bodies | |
| ZA201209424B (en) | Method for delivering an active agent | |
| BRPI0920383A2 (pt) | método para minimizar o diâmetro de uma solução de uréia, solução de uréia e uso de um tensoativo em solução de uréia | |
| BR112013018876A2 (pt) | dispositivo de travamento, dispositivo de transferência com o mesmo, e método para controlar o dispositivo de travamento | |
| BR112013009360A2 (pt) | sistema e método para produção de ar líquido, armazenamento de energia e liberação de energia | |
| BR112012025375A2 (pt) | compósito absorvente, artigo de cuidade pessoal absorvente e método para preparação de um artigo de cuidado pessoal absorvente | |
| WO2012080833A3 (en) | Controlled release dosage forms | |
| BR112013014540A2 (pt) | artigo absorvente e método para preparar o mesmo | |
| BR112012031981A2 (pt) | composição aquosa de ingrediente ativo, processo, uso, método para controlar fungos fitopatogênicos e semente | |
| BR112013022411A2 (pt) | artigo absorvente e método para preparar um artigo absorvente | |
| PL2770827T3 (pl) | Kompozycja, sposób otrzymywania kompozycji i zawierająca ją formulacja fitosanitarna | |
| PL2616329T3 (pl) | Statek z otworem do wyjmowania systemu zasilania w energię | |
| ITTO20120461A1 (it) | Agente per il controllo di ectoparassiti di animali. | |
| EP2684868A4 (en) | SUBSTITUTED AROMATIC COMPOUND, HYDROGELIZING AGENTS, HYDROGELS AND METHOD FOR GELING AQUEOUS SAMPLES | |
| BR112013009347A2 (pt) | composição, uso de um composto, método para produzir uma camada de liberação adesiva, agente de liberação e película de liberação. | |
| CL2013000292A1 (es) | Metodo de prepararcion de una composicion que comprende partículas submicrónicas que contienen o estan cubiertas por un agente activo; composicion que incluye partículas submicrónicas que contienen o estan recubiertas con una capa submicrónica de al menos un biocida. | |
| BR112014008527A2 (pt) | núcleo absorvente | |
| BR112012022712A2 (pt) | artigo abrasivo, e método para reformar um artigo abrasivo | |
| PT2704698T (pt) | Forma farmacêutica para a libertação controlada de princípios activos | |
| EP2643057A4 (en) | IMPLANT FOR THE CONTROLLED RELEASE OF PHARMACEUTICALLY ACTIVE AGENTS | |
| BR112015009710A2 (pt) | composição para tratamento de um substrato, métodos de tratamento de um substrato e para preparação da composição e agente condicionador | |
| TH1301006133B (th) | วัสดุคอมโพสิต (Composite) สำหรับควบคุมการปลดปล่อยสารบำบัดหลุม (well treatment agent) |